Abstract Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.
Preventive treatments for breast cancer: recent developments
J. Alés‐Martínez,A. Ruíz,J. Chacón,A. L. Hernández,M. Ramos,O. Córdoba,E. Aguirre,A. Barnadas,C. Jara,Silvina Mariana González,A. Plazaola,J. Florián,R. Andrés,P. Rovira,A. Frau
Published 2014 in Clinical and Translational Oncology
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Clinical and Translational Oncology
- Publication date
2014-12-02
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-30 of 30 references · Page 1 of 1
CITED BY
Showing 1-8 of 8 citing papers · Page 1 of 1